Author: Susan Kelly
MedTech Dive February 2026
What Happened
Medtronic received FDA 510(k) clearance for its next-generation robotic spine surgery system called Stealth AXiS. The platform combines:
-
AI-based surgical planning
-
Real-time navigation
-
Robotic guidance
The system is modular and designed for both hospital operating rooms and ambulatory surgery centers (ASCs).
Why This Matters
Medtronic is aggressively expanding in the $15 billion cranial and spinal technologies market, where it says the sector is at a “technology inflection point.”
Stealth AXiS builds on:
-
The 2018 Mazor Robotics acquisition ($1.64B)
-
Medtronic’s StealthStation navigation platform
-
Its AiBLE ecosystem (AI, data integration, and surgical analytics)
Key differentiator:
Surgeons can visualize anatomic motion and alignment in real time without repeated imaging, potentially reducing radiation exposure and improving intraoperative decision-making.
Strategic Implications
-
Market Share Expansion
Medtronic told investors it is gaining share in spine and cranial technologies. -
AI Ecosystem Leverage
AiBLE is reportedly installed at 10x the scale of the nearest competitor, giving Medtronic a data advantage in procedural planning and analytics. -
Platform Optionality
The architecture may expand to:-
Cranial applications
-
ENT procedures
(Pending additional FDA clearance)
-
-
Competitive Landscape
Major players include:-
Johnson & Johnson (DePuy Synthes – planning spinout in 18–24 months)
-
Globus Medical
-
Stryker (recently exited U.S. spinal implants but active in enabling tech)
-
Broader Trend
Spine robotics is transitioning from:
Navigation-assisted surgery → AI-guided, data-driven robotic ecosystems
The future competitive battle appears to be:
Hardware + AI + Installed Base + Data Integration
Medtronic is positioning Stealth AXiS as not just a robot — but a connected surgical intelligence platform.